FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080968178> ?p ?o ?g. }

• W3080968178 endingPage "107385" @default.
• W3080968178 startingPage "107385" @default.
• W3080968178 abstract "Purpose The purpose of the study was to investigate the potential correlation between plasma concentration of the newer antiseizure medication (ASM) perampanel (PMP) and both tolerability and seizure control in patients with epilepsy. Methods The study design was multicenter, open, and prospective. Plasma samples were collected in the morning 12 h apart from once-a-day bedtime PMP dose. Perampanel tolerability was assessed on the day of drug monitoring by clinical examination and patients' interview. Response to PMP was defined as ≥50% reduction from baseline seizure frequency (pretreatment). The main outcomes were the comparisons of PMP plasma concentration-to-weight-adjusted dose ratio (C/D) [(μg/mL)/(mg/kg/day)] between patients with and without PMP-related adverse effects (AEs) and between responders and nonresponders. Results Ninety-seven patients (54% men), mean ± SD age 36 ± 14 years were enrolled in the study. The mean PMP dose was 6.7 ± 2.3 mg, drug treatment averaged 46 ± 34 weeks. The mean plasma concentration was 360 ± 268 ng/mL (range: 37–1213 ng/mL). Forty patients (41%) reported at least one AE, mainly dizziness and behavioral changes. No significant difference was found in median PMP C/Ds between patients with (2.94) and without (2.76) AEs, otherwise comparable for clinical variables. Forty-four patients (45%) were responders, at a median PMP C/D of 3.10, similar to the value of 2.76 found in nonresponders. These two groups also overlapped for clinical characteristics. Conclusion This is the first prospective real-life study to evaluate the relationship between PMP plasma concentrations, seizure control, and AEs. In line with the few real-world available data, we did not find any significant correlation between PMP plasma concentrations and both tolerability and seizure control." @default.
• W3080968178 created "2020-09-01" @default.
• W3080968178 creator A5005354511 @default.
• W3080968178 creator A5009309469 @default.
• W3080968178 creator A5013355586 @default.
• W3080968178 creator A5013762285 @default.
• W3080968178 creator A5018263451 @default.
• W3080968178 creator A5020025629 @default.
• W3080968178 creator A5025475711 @default.
• W3080968178 creator A5032876422 @default.
• W3080968178 creator A5034063119 @default.
• W3080968178 creator A5035940777 @default.
• W3080968178 creator A5038981019 @default.
• W3080968178 creator A5057163411 @default.
• W3080968178 creator A5063136168 @default.
• W3080968178 creator A5064355751 @default.
• W3080968178 creator A5068090228 @default.
• W3080968178 creator A5081023621 @default.
• W3080968178 creator A5083300368 @default.
• W3080968178 creator A5084637368 @default.
• W3080968178 creator A5091672479 @default.
• W3080968178 date "2020-11-01" @default.
• W3080968178 modified "2023-10-14" @default.
• W3080968178 title "Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study" @default.
• W3080968178 cites W1551373999 @default.
• W3080968178 cites W1970988925 @default.
• W3080968178 cites W2058945163 @default.
• W3080968178 cites W2083402697 @default.
• W3080968178 cites W2324286688 @default.
• W3080968178 cites W2512951033 @default.
• W3080968178 cites W2615944722 @default.
• W3080968178 cites W2797635914 @default.
• W3080968178 cites W2808354832 @default.
• W3080968178 cites W2810444319 @default.
• W3080968178 cites W2883635079 @default.
• W3080968178 cites W2912177640 @default.
• W3080968178 cites W2920200341 @default.
• W3080968178 cites W2940397425 @default.
• W3080968178 doi "https://doi.org/10.1016/j.yebeh.2020.107385" @default.
• W3080968178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32858369" @default.
• W3080968178 hasPublicationYear "2020" @default.
• W3080968178 type Work @default.
• W3080968178 sameAs 3080968178 @default.
• W3080968178 citedByCount "6" @default.
• W3080968178 countsByYear W30809681782021 @default.
• W3080968178 countsByYear W30809681782022 @default.
• W3080968178 countsByYear W30809681782023 @default.
• W3080968178 crossrefType "journal-article" @default.
• W3080968178 hasAuthorship W3080968178A5005354511 @default.
• W3080968178 hasAuthorship W3080968178A5009309469 @default.
• W3080968178 hasAuthorship W3080968178A5013355586 @default.
• W3080968178 hasAuthorship W3080968178A5013762285 @default.
• W3080968178 hasAuthorship W3080968178A5018263451 @default.
• W3080968178 hasAuthorship W3080968178A5020025629 @default.
• W3080968178 hasAuthorship W3080968178A5025475711 @default.
• W3080968178 hasAuthorship W3080968178A5032876422 @default.
• W3080968178 hasAuthorship W3080968178A5034063119 @default.
• W3080968178 hasAuthorship W3080968178A5035940777 @default.
• W3080968178 hasAuthorship W3080968178A5038981019 @default.
• W3080968178 hasAuthorship W3080968178A5057163411 @default.
• W3080968178 hasAuthorship W3080968178A5063136168 @default.
• W3080968178 hasAuthorship W3080968178A5064355751 @default.
• W3080968178 hasAuthorship W3080968178A5068090228 @default.
• W3080968178 hasAuthorship W3080968178A5081023621 @default.
• W3080968178 hasAuthorship W3080968178A5083300368 @default.
• W3080968178 hasAuthorship W3080968178A5084637368 @default.
• W3080968178 hasAuthorship W3080968178A5091672479 @default.
• W3080968178 hasConcept C118552586 @default.
• W3080968178 hasConcept C126322002 @default.
• W3080968178 hasConcept C188816634 @default.
• W3080968178 hasConcept C19720800 @default.
• W3080968178 hasConcept C197934379 @default.
• W3080968178 hasConcept C23131810 @default.
• W3080968178 hasConcept C2778186239 @default.
• W3080968178 hasConcept C2778375690 @default.
• W3080968178 hasConcept C2778537899 @default.
• W3080968178 hasConcept C2780836401 @default.
• W3080968178 hasConcept C71924100 @default.
• W3080968178 hasConcept C90924648 @default.
• W3080968178 hasConceptScore W3080968178C118552586 @default.
• W3080968178 hasConceptScore W3080968178C126322002 @default.
• W3080968178 hasConceptScore W3080968178C188816634 @default.
• W3080968178 hasConceptScore W3080968178C19720800 @default.
• W3080968178 hasConceptScore W3080968178C197934379 @default.
• W3080968178 hasConceptScore W3080968178C23131810 @default.
• W3080968178 hasConceptScore W3080968178C2778186239 @default.
• W3080968178 hasConceptScore W3080968178C2778375690 @default.
• W3080968178 hasConceptScore W3080968178C2778537899 @default.
• W3080968178 hasConceptScore W3080968178C2780836401 @default.
• W3080968178 hasConceptScore W3080968178C71924100 @default.
• W3080968178 hasConceptScore W3080968178C90924648 @default.
• W3080968178 hasLocation W30809681781 @default.
• W3080968178 hasOpenAccess W3080968178 @default.
• W3080968178 hasPrimaryLocation W30809681781 @default.
• W3080968178 hasRelatedWork W1981958881 @default.
• W3080968178 hasRelatedWork W2099278102 @default.
• W3080968178 hasRelatedWork W2747767288 @default.
• W3080968178 hasRelatedWork W2783720180 @default.

• next